BrainXell: Funding, Investors & Team (Oct 2026)
BrainXell provides a range of high-purity, iPSC-derived human neurons for research and development with a focus on drug discovery. BrainXell was founded in 2015 by Prof. Su-Chun Zhang in conjunction with the Discovery to Product (D2P) program of University of Wisconsin- Madison and operates out of a new facility in University Research Park. The company is based on the proprietary technology of directed differentiation of human stem cells (including induced pluripotent stem cells) to highly enriched subclasses of neurons.
BrainXell has raised $13.2M across 1 funding round on record, the most recent an undisclosed round of $13.2M announced in Sep 2021.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BrainXell Company Profile and Key Stats
Latest funding round on record: Sep 2021.
BrainXell Funding Rounds
BrainXell Founders and Leadership Team
Contact details for the BrainXell team: 1 of 1 has an email address on file.
Start 14-day free trial →BrainXell Funding Compared to Other Biotechnology Startups
BrainXell's latest round of $13.2M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BrainXell in Biotechnology and Madison
Companies Similar to BrainXell
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
BrainXell Funding FAQs
What does BrainXell do?
BrainXell provides a range of high-purity, iPSC-derived human neurons for research and development with a focus on drug discovery. BrainXell was founded in 2015 by Prof. Su-Chun Zhang in conjunction with the Discovery to Product (D2P) program of University of Wisconsin- Madison and operates out of a new facility in University Research Park. The company is based on the proprietary technology of directed differentiation of human stem cells (including induced pluripotent stem cells) to highly enriched subclasses of neurons.
How much funding has BrainXell raised?
BrainXell has raised $13.2M across 1 round on record. The most recent is an undisclosed round of $13.2M announced in Sep 2021.
When did BrainXell last raise funding?
BrainXell's most recent funding round on record is an undisclosed round of $13.2M, announced in Sep 2021.
Who is the CEO of BrainXell?
Shouming Du is listed as CEO at BrainXell.
Where is BrainXell headquartered?
BrainXell is based in Madison, Wisconsin, United States.
How many employees does BrainXell have?
BrainXell is in the 11-50 employee band.
How does BrainXell's funding compare to other Biotechnology startups?
BrainXell's latest round of $13.2M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's BrainXell Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BrainXell is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.